H.I.G. BioHealth Partners

Summary

The main department of described VC is located in the Miami. The venture was found in North America in United States.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Arvelle Therapeutics, On Target Laboratories, NeuWave Medical. Among the most popular fund investment industries, there are Pharmaceutical, Medical Device. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.

This organization was formed by Sami Mnaymneh, Tony Tamer. Besides them, we counted 5 critical employees of this fund in our database.

Considering the real fund results, this VC is 21 percentage points more often commits exit comparing to other organizations. This H.I.G. BioHealth Partners works on 11 percentage points less the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2015. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2016. The fund is generally included in 2-6 deals every year.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the H.I.G. BioHealth Partners, startups are often financed by Quaker Partners, New Enterprise Associates, MPM Capital. The meaningful sponsors for the fund in investment in the same round are New Enterprise Associates, Versant Ventures, Quaker Partners. In the next rounds fund is usually obtained by Quaker Partners, New Enterprise Associates, OUP (Osage University Partners).